Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1.

Zamarin D, García-Sastre A, Xiao X, Wang R, Palese P. · 2005

Read Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. by Zamarin D, García-Sastre A, Xiao X, Wang R, Palese P. (2005) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1238739.txt.

Introduction

Zamarin and colleagues traced how a flu protein kills cells in 2005. The protein, PB1-F2, is a small part of influenza virus. It settles in mitochondria, the energy hubs of cells. Earlier work showed it triggers cell death, but the route was unclear.

Cells with the protein reacted more strongly to death signals. Tests on mouse liver mitochondria showed a key protein leaking out. The viral protein bound two gate proteins in mitochondrial walls. Those gates control what passes between cell compartments. Zamarin links those contacts to the death effect.

Catalog record

CREATORZamarin D, García-Sastre A, Xiao X, Wang R, Palese P.
YEAR2005
COLLECTIONPAPERS
FORMATTXT
FILE SIZE69 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC1238739

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Influenza Virus PB1-F2 Protein Induces Cell Death through Mitochondrial ANT3 and VDAC1 By Dmitriy Zamarin, Adolfo García-Sastre, Xiaoyao Xiao, Rong Wang, Peter Palese, Skip Virgin Published in: PLoS Pathogens DOI: 10.1371/journal.ppat.0010004 ABSTRACT Abstract The influenza virus PB1-F2 is an 87-amino acid mitochondrial protein that previously has been shown to induce cell death, although the mechanism of apoptosis induction has remained unclear. In the process of characterizing its mechanism of action we found that the viral PB1-F2 protein sensitizes cells to apoptotic stimuli such as tumor necrosis factor alpha, as demonstrated by increased cleavage of caspase 3 substrates in PB1-F2-expressing cells. Moreover, treatment of purified mouse liver mitochondria with recombinant PB1-F2 protein resulted in cytochrome c release, loss of the mitochondrial membrane potential, and enhancement of tBid-induced mitochondrial permeabilization, suggesting a possible mechanism for the observed cellular sensitization to apoptosis. Using glutathione-S-transferase pulldowns with subsequent mass spectrometric analysis, we identified the mitochondrial interactors of the PB1-F2 protein and showed that the viral protein uniquely interacts with the inner mitochondrial membrane adenine nucleotide translocator 3 and the outer mitochondrial membrane voltage-dependent anion channel 1, both of which are implicated in the mitochondrial permeability transition during apoptosis. Consistent with this interaction, blockers of the permeability transition pore complex (PTPC) inhibited PB1-F2-induced mitochondrial permeabilization. Based on our findings, we propose a model whereby the proapoptotic PB1-F2 protein acts through the mitochondrial PTPC and may play a role in the down-regulation of the host immune response to infection. INTRODUCTION Influenza virus infection results in the activation of cellular pathways aimed at inhibition of viral replication and induction of an antiviral state [1]. To overcome the antiviral signaling, influenza viruses evolved accessory proteins, such as NS1 and PB1-F2, that have been proposed to down-modulate different aspects of the host immune response [2,3]. While the NS1 protein has been shown to play a role in the inhibition of the type I interferon response, the function of the PB1-F2 protein remains elusive. PB1-F2 is a novel 87-amino acid protein serendipitously identified in an alternate reading frame of the PB1 gene of the influenza A/PR/8/34 virus [3]. Initial studies revealed that the protein localizes to mitochondria resulting in the alteration of mitochondrial morphology, dissipation of mitochondrial membrane potential, and cell death, which was more pronounced in cells of immune origin [3]. The basic amphipathic helix in the C-terminal region of the PB1-F2 protein was subsequently determined to be responsible for its mitochondrial localization [4,5]. Synthetic peptides derived from the C-terminal domain of the protein were shown to have an ability to oligomerize and nonspecifically permeabilize lipid bilayer membranes [6,7], properties observed with some known cellular mitochondrial apoptotic mediators [8,9]. Despite these findings, however, the precise mechanism and function of PB1-F2-induced apoptosis remains unclear. Regulation of the mitochondrial permeabilization has been implicated in the life cycle of several known human pathogens [10,11]. Indeed, stable cell lines overexpressing the antiapoptotic proteins of the Bcl-2 family are less permissive to influenza viral replication than their parental cell lines [12–14], highlighting the importance of the role of the mitochondrial apoptotic pathways in influenza virus pathogenesis. Cellular apoptotic signaling to mitochondria proceeds through activation of the members of the proapoptotic Bcl-2 family BH3-only proteins such as Bid, which exert their effects through induction of the release of several mitochondrial apoptotic mediators, such as cytochrome c, apoptosis-inducing factor, endonuclease G, Smac/Diablo, and Omi/HtrA2 [15]. The exact mechanism leading to the mitochondrial permeabilization is still under investigation, but is known to involve cellular apoptotic mediators of the Bcl-2 family, such as Bak and Bax, and proteins constituting the permeability transition pore complex (PTPC), such as the adenine nucleotide translocator 3 (ANT3) in the inner mitochondrial membrane and the voltage-dependent anion channel 1 (VDAC1) in the outer mitochondrial membrane [16–19]. In view of the possible contribution of the PB1-F2 protein to influenza viral pathogenesis, we sought to determine the role of the protein in modulation of host immune response and to further elucidate its mechanism of action. We show that the mitochondrial permeabilization by the PB1-F2 protein renders cells sensitive to the proapoptotic effect of tumor necrosis factor alpha (TNFα) through tBid signaling. Furthermore, our results indicate that PB1-F2-induced apoptosis proceeds through a unique mechanism involving its interaction with the ANT3 and VDAC1 proteins of the PTPC at the inner and outer mitochondrial membranes, respectively. With the use of ANT3-specific inhibitor, we conclude that PB1-F2 directly permeabilizes mitochondria in an ANT3-dependent manner. The results of our studies provide a deeper insight into the function of the PB1-F2 protein and underscore the role of the PTPC in mitochondrial permeabilization and cell death in influenza virus-infected cells. RESULTS PB1-F2 Protein Sensitizes Transfected Cells to Apoptotic Stimuli We investigated whether transient expression of the influenza virus PB1-F2 protein would enhance cell death by intrinsic and extrinsic proapoptotic stimuli (Figure 1). To achieve maximal transient transfection efficiency of the PB1-F2 protein, the proapoptotic effect of the agents was initially assayed in PB1-F2-transfected 293T cells, where apoptosis was detected by cleavage of poly A ribose polymerase (PARP), a direct substrate of caspase 3 (Figure 1A). The unrelated influenza virus protein, nucleoprotein (NP), which does not induce apoptosis, was used as a control. Reduction of full-length PARP with a concomitant increase in cleaved PARP product was seen in PB1-F2-transfected cells in response to DNA damage caused by UV irradiation and cisplatin, when compared to the control (Figure 1A). Treatment of PB1-F2-transfected cells with 50 ng/ml of TNFα or with 5 ng/ml of TNF-related apoptosis-inducing ligand resulted in significant increase in PARP cleavage, as compared to the control (Figure 1A). In view of the findings that PB1-F2 sensitized cells to both extrinsic and intrinsic apoptotic stimuli, we tested whether the PB1-F2-expressing cells are also sensitized to death due to detachment from the growth matrix (anoikis). The activation of anoikis has also been shown to involve proapoptotic members of the BH3 family [20,21]. Indeed, PB1-F2 also sensitized cells to death by anoikis, as demonstrated by rapid membrane blebbing and fragmentation of trypsinized human lung epithelial A549 cells transfected with a construct expressing PB1-F2 (Figure 1B) [22]. To determine whether the PB1-F2-expressing cells were indeed undergoing apoptosis, we labeled PB1-F2-transfected A549 cells with M30 antibody to caspase-cleaved cytokeratin. Interestingly, in the absence of other apoptotic stimuli, only a small proportion of PB1-F2-expressing cells underwent apoptosis (Figure 1C), which could explain the relatively low proapoptotic effect of the PB1-F2 protein observed in the assays above. Overall, these results suggest that the PB1-F2 protein enhances the effect of cellular proapoptotic stimuli. [Figure: PB1-F2 Protein Sensitizes Cells to Apoptosis in Response to Cytotoxic Stimuli(A) Expression of PB1-F2 protein enhanced cleavage of poly-A ribose polymerase (PARP) in response to cytotoxic agents. 293T cells were transfected with either PB1-F2 (F2) or influenza virus NP (NP) for 24 h and were subsequently treated for 6 h with 50 ng/ml TNFα, 5 ng/ml TNF-related apoptosis-inducing ligand, 100 μM cisplatin, or UV-irradiation at 60 J/m2 as indicated. All cells were collected 6 h later, lysed, and processed by immunoblotting for cleaved PARP.(B) PB1-F2 protein predisposes cells to death by anoikis. A549 cells were transfected either with empty vector or with PB1-F2 and trypsinized 24 h post-transfection. Cells were incubated in PBS with 0.3% BSA

Read the complete text